NewAmsterdam Pharma Company
NAMS • NASDAQ
NewAmsterdam Pharma Company is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Michael Harvey Davidson Facp., with a market cap of $4.0B.
Market Cap$4.0B
Employees29.0
CEOMichael Harvey Davidson Facp.
CountryNetherlands
Healthcare
Biotechnology
Next EarningsMay 7, 2026 · In 3 weeksQ1 2026
Financials
NewAmsterdam Pharma Company FAQ
Common questions about NewAmsterdam Pharma Company
NewAmsterdam Pharma Company is scheduled to report earnings for Q1 2026 on May 7, 2026. Analysts estimate revenue of $1.5M.
NewAmsterdam Pharma Company has approximately 29 employees.